NCT05397132View on ClinicalTrials.gov

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

Hematologic Malignancy

Interventions

GENETIC

Blood draw

Patients will provide a blood draw for research and repository

Trial Locations (1)

27710

RECRUITING

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER